In the hormone-dependent breast cancer cell line (BT474), TET1 can suppress invasion and adhesion [63], whereas in triple-negative breast cancer cells (MDA-MB-231), TET1 acts in an opposite manner, promoting cell proliferation and migration via activation of the oncogenic PI3K–mTOR pathway [61]. This evidence concerns the gene TET1 and breast cancer.